These findings suggest that low levels of lnc-EGFR and high levels of both SNHG1 and lincRNA-Cox2 are linked to the pathogenesis of RRMS, disease activity, and future progression. This evidence concerns the gene SNHG1 and relapsing-remitting multiple sclerosis.